Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer

Journal of Controlled Release

Volumn 91, Issue 1-2, 2003, Pages 147-155

  Almond, Brett A ^a   Hadba, Ahmad R ^a   Freeman, Shema T ^a   Cuevas, Brian J ^a   York, Amanda M ^a   Detrisac, Carol J ^b   Goldberg, Eugene P ^a  

^a University of Florida   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Albumin microspheres; Breast cancer model; Intratumoral chemotherapy; Localized drug delivery; Mitoxantrone

Indexed keywords

CHEMOTHERAPY; TOXICITY; TUMORS;

ALBUMIN MICROSPHERES;

CONTROLLED DRUG DELIVERY;

ALBUMIN; ANTINEOPLASTIC AGENT; DRUG CARRIER; MICROSPHERE; MITOXANTRONE; ALBUMINOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MODEL; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TOXICITY TESTING; ADENOCARCINOMA; ANIMAL; ARTICLE; BODY WEIGHT; C3H MOUSE; DRUG EFFECT; EXPERIMENTAL NEOPLASM; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; SURVIVAL;

ADENOCARCINOMA; ALBUMINS; ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; MITOXANTRONE; SURVIVAL ANALYSIS;

EID: 0141921468     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00214-1     Document Type: Conference Paper

References (19)

1. L.A.G. Ries, M.P. Eisner, C.L. Kosary, B.F. Hankey, B.A. Miller, L. Clegg, B.K. Edwards, Seer cancer statistics review, 1973-1998. http://seer.cancer.gov/Publications/CSR1973_1998/2001.
2. Breast Cancer Facts and Figures 2001-2002. American Cancer Society, Atlanta, GA, 2002.
3. Vegt P.D., Debruyne F.M., van der Meijden A.P. Bacillus calmette-guérin in superficial bladder cancer: Consensus and controversies. Eur. Urol. 27:(2):1995;89-95.
4. Venook A.P. Regional strategies for managing hepatocellular carcinoma. Oncology (Huntington). 14:(3):2000;347-354. and discussion 354, 359, 363-364.
5. Walter K.A., Tamargo R.J., Olivi A., Burger P.C., Brem H. Intratumoral chemotherapy. Neurosurgery. 37:(6):1995;1128-1145.
6. Haroun R.I., Brem H. Local drug delivery. Curr. Opin. Oncol. 12:(3):2000;187-193.
7. Goldberg E.P., Hadba A.R., Almond B.A., Marotta J.S. Intratumoral cancer chemotherapy and immunotherapy: Opportunities for nonsystemic preoperative drug delivery. J. Pharm. Pharmacol. 54:(2):2002;159-180.
8. A.R. Hadba, Synthesis, properties, and in vivo evaluation of sustained release albumin-mitoxantrone microsphere formulations for nonsystemic treatment of breast cancer and other high mortality cancers, Ph. D. Dissertation. University of Florida, Gainesville, 2001.
9. Berkland C., Kim K.K., Pack D.W. Fabrication of plg microspheres with precisely controlled and monodisperse size distributions. J. Controlled Release. 73:(1):2001;59-74.
10. Faulds D., Balfour J.A., Chrisp P., Langtry H.D. Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. Drugs. 41:(3):1991;400-449.
11. Dunn C.J., Goa K.L. Mitoxantrone: A review of its pharmacological properties and use in acute nonlymphoblastic leukaemia. Drugs Aging. 9:(2):1996;122-147.
12. Nagel J.D., Varossieau F.J., Dubbelman R., ten Bokkel Huinink W.W., McVie J.G. Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration. Cancer Chemother. Pharmacol. 29:(6):1992;480-484.
13. Knepp W.A., Jayakrishnan A., Quigg J.M., Sitren H.S., Bagnall J.J., Goldberg E.P. Synthesis, properties, and intratumoral evaluation of mitoxantrone-loaded casein microspheres in lewis lung carcinoma. J. Pharm. Pharmacol. 45:(10):1993;887-891.
14. Baitchev G., Gorchev G., Deliisky T., Popovska S., Raitcheva T.Z. Perioperative locoregional application of mitoxantrone in patients with early breast carcinoma. J. Chemother. 13:(4):2001;440-443.
15. Celikoglu S.I., Karayel T., Demirci S., Celikoglu F., Cagatay T. Direct injection of anti-cancer drugs into endobronchial tumours for palliation of major airway obstruction. Postgrad. Med. J. 73:(857):1997;159-162.
16. A.R. Hadba, J.S. Marotta, E.P. Goldberg, Effect of loading method on drug content and in vitro release of mitoxantrone from albumin microspheres, Sixth World Biomaterials Congress, Kamela, Hawaii, 2000, p. 770.
17. Longo W.E., Iwata H., Lindheimer T.A., Goldberg E.P. Preparation of hydrophilic albumin microspheres using polymeric dispersing agents. J. Pharm. Sci. 71:(12):1982;1323-1328.
18. Corbett T.H., Griswold D.P. Jr., Roberts B.J., Peckham J.C., Schabel F.M. Jr. Biology and therapeutic response of a mouse mammary adenocarcinoma (16/c) and its potential as a model for surgical adjuvant chemotherapy. Cancer Treat. Rep. 62:(10):1978;1471-1488.
19. B.A. Almond, Mitoxantrone-Loaded Albumin Microspheres for Localized Intratumoral Chemotherapy of Breast Cancer, Ph.D. Dissertation, University of Florida, Gainesville, 2002.